04/06/2020
7:41 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2020
3:13 PM | Acceleron Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2020
3:10 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
8:26 AM | Acceleron Pharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2020
5:01 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4/A
| |
02/10/2020
4:50 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 4/A
| |
01/27/2020
3:14 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2020
6:32 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:59 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:48 PM | Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:45 PM | Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:41 PM | Acceleron Pharma (Issuer)
George Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:37 PM | Acceleron Pharma (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:33 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:27 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:21 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
4:18 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2020
3:20 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2020
3:36 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:51 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:48 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:45 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:41 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:37 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:32 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:24 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
8:20 PM | Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2019
5:39 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
5:19 PM | Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2019
3:35 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2019
7:04 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2019
4:26 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
9:16 AM | Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
11/08/2019
4:27 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
6:57 AM | Acceleron Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
6:54 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2019
4:12 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2019
7:25 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2019
7:24 PM | Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2019
7:23 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2019
7:22 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2019
7:21 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2019
3:18 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
3:09 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2019
4:49 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2019
3:26 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2019
8:51 AM | Acceleron Pharma (Filer)
| Form CT ORDER
| |
06/28/2019
6:25 PM | Acceleron Pharma (Issuer)
George Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
5:08 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:47 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
3:39 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:38 PM | Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/07/2019
3:06 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:09 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2019
3:22 PM | Acceleron Pharma (Filer)
| Form DEFA14A
| |
04/12/2019
3:20 PM | Acceleron Pharma (Filer)
| Form DEF 14A
| |
04/11/2019
3:58 PM | Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2019
3:58 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2019
3:58 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2019
3:58 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2019
4:19 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2019
5:07 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:28 PM | Acceleron Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2019
3:12 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
12:50 PM | Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
01/29/2019
4:50 PM | Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:49 PM | Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:48 PM | Acceleron Pharma (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:47 PM | Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:47 PM | Acceleron Pharma (Issuer)
Maniatis Tom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:46 PM | Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:45 PM | Acceleron Pharma (Issuer)
George Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:44 PM | Acceleron Pharma (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:43 PM | Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:42 PM | Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:41 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:40 PM | Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:38 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:37 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2019
4:00 PM | Acceleron Pharma (Subject)
CELGENE CORP /DE/ (Filed by)
| Form SC 13D/A
| |
01/22/2019
4:00 PM | Acceleron Pharma (Issuer)
CELGENE CORP /DE/ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2019
3:44 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2019
3:43 PM | Acceleron Pharma (Filer)
| Form 424B2
| |
01/14/2019
4:29 PM | Acceleron Pharma (Filer)
| Form 424B5
| |
01/07/2019
6:17 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2019
5:36 PM | Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
5:35 PM | Acceleron Pharma (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
5:34 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
5:34 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
3:22 PM | Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
7:34 AM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2018
3:13 PM | Acceleron Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
3:10 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2018
10:36 AM | Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
08/31/2018
6:00 PM | Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
3:22 PM | Acceleron Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2018
3:30 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2018
4:01 PM | Acceleron Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2018
3:47 PM | Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2018
3:44 PM | Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
